Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer

Abstract

Verteporfin PDT-induced tumour necrosis in locally advanced pancreatic cancer is feasible and safe. It can be delivered with a much shorter drug light interval and with less photosensitivity than with older compounds.